SkinHealth Systems Q3 revenue beats estimates
SKIN•SkinHealth Systems reported Q3 revenue of $69.2 million, down year over year but above the $67.78 million analyst estimate, and adjusted EBITDA of $13.4 million, ahead of estimates. It forecast 2026 net sales of $281 million to $287 million and adjusted EBITDA of $48 million to $50 million.
1. Quarterly results
Q3 revenue was $69.2 million, beating the $67.78 million analyst consensus, while the company reported a net loss of $900,000. Adjusted EBITDA was $13.4 million, above the $6.02 million consensus estimate.
2. Outlook and drivers
The company forecast 2026 net sales of $281 million to $287 million and adjusted EBITDA of $48 million to $50 million. It said consumables sales returned to growth in Q3; lower inventory charges and tariff-related recoveries lifted gross margin, while reduced personnel and professional fees lowered operating expenses. The company also retired its 2026 debt as planned.
